BARDA is terminating 22 mRNA vaccine development investments

Save
1 month ago
5
News Secretary Kennedy @SecKennedy · 11h We reviewed the science listened to the experts and acted. BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We’re shifting that funding toward safer broader vaccine platforms that remain effective even as viruses mutate.

Secretary Kennedy

@SecKennedy
·
11h
We reviewed the science, listened to the experts, and acted. BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We’re shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.

Loading comments...